Bristol Myers Squibb filed with the SEC on May 28, 2026, regarding increased institutional ownership and share purchases.

The entities involved

• Bristol-Myers Squibb →

  American pharmaceutical company

  • Bristol-Myers Squibb is developing innovative treatments and supporting Cyprus' national effort in haematology.Mon 13:45
  • FDA gave tentative approval to Lupin for an alternative formulation of a Bristol-Myers Squibb drug, which Lupin plans to manufacture in Somerset.Mon 09:09
• SEC →

  Slovak company

  • DHS, DOJ, and SEC formed a joint initiative to establish a Trade Fraud Task Force, setting standards for compliance.Mon 17:57
  • The Fidelis Partnership is incorporating in Bermuda and filing for an initial public offering on the NYSE, with principal offices in London and a main office in Dublin.Mon 17:12
• BXP →

  Real-Estate-Investment-Trust

  Nothing else this week.

Related events

• Institutional investors bought and sold shares of Ur Energy Inc. on May 27, 2026, filing required 13F reports with the SEC.Jun 7
• Disclosures were filed with the SEC regarding institutional ownership stakes involving Quantum eMotion Corp, noting a new acquisition of 0.39% in the company.Aug 18
• Citigroup filed with the SEC regarding its institutional holdings on August 8, 2026.Aug 8
• General Dynamics filed with the SEC on June 6, 2026, regarding required institutional holdings disclosures.Jun 10
• Institutional investors filed holdings reports with the SEC involving Caterpillar Inc.Aug 4